Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
Head-Medical Physics, Department of Radiotherapy, Basavatarakam Indo American Cancer Hospital & Research Institute, Road No: 14, 500034, Hyderabad, Banjara Hills, India.
Strahlenther Onkol. 2021 Aug;197(8):722-729. doi: 10.1007/s00066-021-01769-2. Epub 2021 Apr 14.
Total body irradiation (TBI) can be safely delivered on TomoTherapy (Accuray, Sunnyvale, CA, USA) in both pediatric and adult patients with proper imaging and planning despite the length constraint of 135 cm. To overcome this limitation, two CT (Computed Tomography) scans (CT1& CT2) are taken in patients above 135 cm in height. Adequate junction dose coverage is important in TBI. Presently, there is no clinical report with a focus on the quality of dose distribution at the CT junction in view of the guidelines on quality of coverage from the RTOG. Hence, our main objectives were to evaluate the dose distribution and quality of coverage at the junction in 16 patients who received TBI using TomoTherapy.
PTV(upper) and PTV(lower) along with a junction were created on CT1 and CT2, respectively. Subsequently, the 10 cm junction in the thigh region was divided into five target volumes of 2 cm thickness with dose prescription ranging from 10 to 90% to deliver a total dose equal to 100% when fused.
The D was equal to the prescribed dose in most of the cases ranging from 99.5 to 104% for PTV(upper), 100-103% for PTV(lower), and 99.5-108% for junctional PTVs (1PTV, 2PTV, 3PTV, 4PTV, and 5PTV). The average D doses from PTV(upper) and PTV(lower) were 97 ± 1.4% and 96.7 ± 1.08%, respectively. The average D doses for 1PTV, 2PTV, 3PTV, 4PTV, and 5PTV were 96.1 ± 1.88%, 91.6 ± 1.82%, 87.3 ± 1.5%, 91.6 ± 1.4%, and 96.2 ± 1.5% respectively. Q values ranged between 0.85 and 1.05 and were in concordance with RTOG guidelines.
Since junction-based planning was required for most TBI patients, it is essential to evaluate the quality of dose coverage in the junction for better TBI plans.
尽管最大长度限制为 135cm,但 TomoTherapy(Accuray,加利福尼亚州桑尼维尔)可在儿科和成人患者中安全地进行全身放疗(TBI),只要有适当的成像和计划。为了克服这一限制,身高超过 135cm 的患者需要进行两次 CT(计算机断层扫描)扫描(CT1 和 CT2)。在 TBI 中,足够的交界处剂量覆盖是很重要的。目前,由于 RTOG 关于覆盖质量的指南,没有专门针对 CT 交界处剂量分布质量的临床报告。因此,我们的主要目标是评估 16 名接受 TomoTherapy 治疗的 TBI 患者的剂量分布和交界处的覆盖质量。
在 CT1 和 CT2 上分别为 PTV(上)和 PTV(下)以及交界处创建了计划靶区。随后,将大腿区域的 10cm 交界处分为 5 个 2cm 厚的靶区,剂量处方范围为 10 至 90%,以融合时达到 100%的总剂量。
大多数情况下,PTV(上)的 D 值等于处方剂量,范围从 99.5%至 104%,PTV(下)的 D 值为 100%至 103%,交界处的 PTVs(1PTV、2PTV、3PTV、4PTV 和 5PTV)的 D 值为 99.5%至 108%。PTV(上)和 PTV(下)的平均 D 剂量分别为 97%±1.4%和 96.7%±1.08%。1PTV、2PTV、3PTV、4PTV 和 5PTV 的平均 D 剂量分别为 96.1%±1.88%、91.6%±1.82%、87.3%±1.5%、91.6%±1.4%和 96.2%±1.5%。Q 值在 0.85 至 1.05 之间,与 RTOG 指南一致。
由于大多数 TBI 患者需要基于交界处的计划,因此评估交界处的剂量覆盖质量对于更好的 TBI 计划是至关重要的。